Fulgent Therapeutics
@fulgentgenetics.com
Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics.
Fulgent Therapeutics's Company Logos
Fulgent Therapeutics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#FB5C33
Outrageous Orange
251, 92, 51
12, 96, 59
0, 63, 80, 2
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#414B56
River Bed
65, 75, 86
211, 14, 30
24, 13, 0, 66
About Fulgent Therapeutics
Fulgent Therapeutics is a premier, full-service genomic testing company that is dedicated to transforming patient care in various areas of medicine. With a focus on oncology, anatomic pathology, infectious and rare diseases, and reproductive health, Fulgent offers a diverse testing menu to provide flexible and affordable diagnostics and therapeutics. Founded in 2011, Fulgent has quickly evolved into a leader in the field, leveraging a foundational technology platform to deliver cutting-edge solutions.
By offering a wide range of effective testing options, along with best-in-class service and support, Fulgent is redefining the way medicine is managed for patients and clinicians alike. In addition to their diagnostic expertise, Fulgent is also involved in therapeutic development. They are currently developing drug candidates for a broad range of cancers using a novel nanoencapsulation and targeted therapy platform.
By integrating their fields of expertise, Fulgent aims to become a fully integrated precision medicine company. At Fulgent Therapeutics, they are guided by a set of core values. They prioritize innovation by merging genetics, molecular biology, and computer science to achieve excellence in clinical diagnostics, therapeutic development, and data analysis.
They also place a strong emphasis on customer service and commitment, with a dedicated team of support staff available to answer questions and ensure physicians can focus on their patients. Quality and efficiency are paramount, as Fulgent is a CLIA-certified and CAP-accredited lab, ensuring rigorous quality controls and oversight. They believe in supporting their employees by providing resources for personal and professional growth, creating a workplace that fosters inclusivity, where differences are celebrated.
With their pioneering laboratory, Fulgent Genetics, they were the first to offer copy number variation detection using NGS technology in the United States. Today, they continue to offer an unrivaled catalog of genetic testing, cementing their position as leaders in the field. Overall, Fulgent Therapeutics is committed to developing innovative solutions that improve the everyday lives of patients, while revolutionizing the field of precision medicine
Company type
Public Company
Year founded
2011
Company size
201-500 employees
Related Brands
Tags
Next-generation sequencing diagnostics
Whole genome sequencing
Carrier screening
Pharmacogenetic (PGx) testing
CLIA/CAP genetic testing laboratory
